Longevity TVFree to view

The Big Picture: Covid-19 and Longevity investing

Jim Mellon

Chairman and Founder, Burnbrae Group

The Big Picture: Covid-19 and Longevity investing

 

Phil Newman
Editor-in-Chief Phil has over 25 years of C-level management, marketing and business development expertise in Europe and North America. His creative background has helped him shape unconventional strategies for commercial growth - garnering both awards and investor ROI.

Phil has wide experience of technology transfer and the commercialisation of innovations from both private and institutional sources and this led to his interest in Longevity and the founding of Longevity.Technology.

RELATED ARTICLES

Longevity TV

Exclusive video interview: David Wood demystifies the transhumanist agenda

Phil Newman - 0
As Longevity moves quickly into the mainstream there are terms and legacies that some use to challenge the sector's validity: we explore what it...
Read more
Longevity TV

Video interview: talking senescence with Nina Khera

Phil Newman - 0
Teenage founder of Canadian start-up Biotein hunts a universal phenotype for senescent cells. As we’ve covered in the past, Biotein’s Nina Khera has a mission...
Read more
Longevity TV

Video interview with BioViva’s Liz Parrish

Phil Newman - 0
BioViva and Integrated Health Systems: How many patients in trials? Where are they located? What pipeline stage? As we've covered in the past, BioViva's Liz...
Read more
By Phil Newman

Latest articles

Selfie biomarkers: AI and insurtech implications for Longevity

AI Danny Sullivan - 0
AI firm Lapetus targets the face as a biomarker of aging: one simple picture can open-up a host of opportunities and implications. Wow. Named after...
Read more

Low levels of stress hormone contributes to aging

Cellular Carla Heyworth - 0
When it comes to the stress hormone cortisol, balance is everything, according to a new study in Germany.  There have been plenty of studies that...
Read more

Rejuvenation Roadmap charts life extension progress

Senescence Eleanor Garth - 0
We take a trip down Lifespan.io's Rejuvenation Roadmap – and it's a journey towards Longevity progress. Lifespan.io is a US-based non-profit organisation that seeks to...
Read more

Longevity therapies delivered through skin is a topical issue

Senolytic drugs Eleanor Garth - 0
Non-invasive therapy that comes in a bottle could be the Longevity crème de la crème. Therapeutic substances like arnica, turmeric and witch hazel have been...
Read more
TISSUE/ORGAN | NANOTECH | SENESCENCE | CELLULAR | DRUGS | AI | NEURAL | AGETECH | INVESTMENT

LONGEVITY MARKET | ABOUT US | MY ACCOUNT | SHARE YOUR NEWS | CONTACT US

PRIVACY POLICY | COOKIE POLICY | TERMS AND CONDITIONS | COPYRIGHT POLICY

© Copyright 2020 PERGALI Limited. All rights reserved. PERGALI, Longevity.Technology and their associated logos are trademarks of PERGALI Limited and are the subject of trademark applications or registrations in various countries around the world. All other trademarks are the property of their respective owners. All PERGALI products and services are subject to continuous development. We reserve the right to alter technical specifications without prior notice.